Frédéric Charlotte
Frédéric Charlotte
Adresse e-mail validée de
Citée par
Citée par
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study
F Imbert-Bismut, V Ratziu, L Pieroni, F Charlotte, Y Benhamou, T Poynard
The Lancet 357 (9262), 1069-1075, 2001
Sampling variability of liver biopsy in nonalcoholic fatty liver disease
V Ratziu, F Charlotte, A Heurtier, S Gombert, P Giral, E Bruckert, ...
Gastroenterology 128 (7), 1898-1906, 2005
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
Y Benhamou, M Bochet, V Di Martino, F Charlotte, F Azria, A Coutellier, ...
Hepatology 30 (4), 1054-1058, 1999
Liver fibrosis in overweight patients
V Ratziu, P Giral, F Charlotte, E Bruckert, V Thibault, I Theodorou, L Khalil, ...
Gastroenterology 118 (6), 1117-1123, 2000
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C
T Poynard, V Ratziu, F Charlotte, Z Goodman, J McHutchison, J Albrecht
Journal of hepatology 34 (5), 730-739, 2001
Extrahepatic manifestations of chronic hepatitis C
P Cacoub, T Poynard, P Ghillani, F Charlotte, M Olivi, J Charles Piette, ...
Arthritis & Rheumatism 42 (10), 2204-2212, 1999
Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial
V Ratziu, P Giral, S Jacqueminet, F Charlotte, A Hartemann–Heurtier, ...
Gastroenterology 135 (1), 100-110, 2008
Survival, liver failure, and hepatocellular carcinoma in obesity‐related cryptogenic cirrhosis
V Ratziu, L Bonyhay, V Di Martino, F Charlotte, L Cavallaro, ...
Hepatology 35 (6), 1485-1493, 2002
Recipient-type specific CD4< sup>+</sup> CD25< sup>+</sup> regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus …
A Trenado, F Charlotte, S Fisson, M Yagello, D Klatzmann, BL Salomon, ...
The Journal of clinical investigation 112 (11), 1688-1696, 2003
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease
V Ratziu, J Massard, F Charlotte, D Messous, F Imbert-Bismut, L Bonyhay, ...
BMC gastroenterology 6 (1), 6, 2006
High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses
J Haroche, F Charlotte, L Arnaud, A Von Deimling, Z Hélias-Rodzewicz, ...
Blood 120 (13), 2700-2703, 2012
Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation
J Haroche, F Cohen-Aubart, JF Emile, L Arnaud, P Maksud, F Charlotte, ...
Blood 121 (9), 1495-1500, 2013
Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients
K Belhadj, F Reyes, JP Farcet, H Tilly, C Bastard, R Angonin, E Deconinck, ...
Blood 102 (13), 4261-4269, 2003
Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice
M Sudres, F Norol, A Trenado, S Grégoire, F Charlotte, B Levacher, ...
The Journal of Immunology 176 (12), 7761-7767, 2006
Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B
RP Myers, MH Tainturier, V Ratziu, A Piton, V Thibault, F Imbert-Bismut, ...
Journal of hepatology 39 (2), 222-230, 2003
Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C
T Poynard, M Munteanu, F Imbert-Bismut, F Charlotte, D Thabut, ...
Clinical chemistry 50 (8), 1344-1355, 2004
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy
C Besson, A Goubar, J Gabarre, W Rozenbaum, G Pialoux, FP Châtelet, ...
Blood 98 (8), 2339-2344, 2001
Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity
P Mathurin, J Moussalli, JF Cadranel, V Thibault, F Charlotte, ...
Hepatology 27 (3), 868-872, 1998
A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
R Pais, F Charlotte, L Fedchuk, P Bedossa, P Lebray, T Poynard, V Ratziu
Journal of hepatology 59 (3), 550-556, 2013
Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?
V Leblond, F Davi, F Charlotte, R Dorent, MO Bitker, L Sutton, ...
Journal of Clinical Oncology 16 (6), 2052-2059, 1998
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20